Innovator Ibd 50 Etf Price Patterns
| FFTY Etf | USD 37.94 1.18 3.21% |
Oversold | Overbought |
Innovator IBD Implied Volatility | 0.82 |
Innovator IBD after-hype prediction price | USD 36.83 |
Rule 16 Summary for current Innovator contract - Market Context
Innovator | Build AI portfolio with Innovator Etf |
Innovator IBD After-Hype Price Density Analysis
Next price density |
| Expected price to next headline |
Innovator IBD Estimiated After-Hype Price Volatility
Innovator IBD Etf Price Outlook Analysis
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 2.50 | 0.09 | 0.01 | 5 Events | 2 Events | In 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
37.94 | 36.83 | 0.19 |
|
Innovator IBD Hype Timeline
Innovator IBD 50 is currently traded for 37.94. The entity has historical hype elasticity of 0.09, and average elasticity to hype of competition of -0.01. Innovator is anticipated to increase in value after the next headline, with the price projected to jump to 36.83 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.19%, whereas the daily expected return is currently at 0.16%. The volatility of related hype on Innovator IBD is about 3125.0%, with the expected price after the next announcement by competition of 37.93. Given the investment horizon of 90 days the next anticipated press release will be in 5 days. Innovator IBD Basic Forecasting Models provides a cross-check on projections for Innovator IBD. The model set adds a statistical reference.Innovator IBD Related Hype Analysis
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FDIF | Fidelity Disruptors ETF | 0.44 | 3 per month | 0.00 | -0.06 | 1.34 | -1.85 | 4.84 | |
| SGLC | Rbb Fund | -0.16 | 1 per month | 1.15 | 0.01 | 1.35 | -1.60 | 4.96 | |
| ACES | ALPS Clean Energy | -0.38 | 4 per month | 0.00 | -0.01 | 2.90 | -2.96 | 10.23 | |
| TRFM | ETF Series Solutions | -0.43 | 3 per month | 1.51 | 0.01 | 1.95 | -2.68 | 6.79 | |
| TMFE | Motley Fool Capital | 0.00 | 0 per month | 0.00 | -0.06 | 0.98 | -1.25 | 3.25 | |
| FEBT | AIM ETF Products | -0.01 | 1 per month | 0.48 | 0.02 | 0.56 | -0.85 | 2.20 | |
| BMVP | Invesco Bloomberg MVP | 0.19 | 1 per month | 0.54 | 0.14 | 1.10 | -1.04 | 3.20 | |
| XSEP | FT Cboe Vest | 0.18 | 2 per month | 0.31 | -0.01 | 0.40 | -0.55 | 1.46 | |
| RZG | Invesco SP SmallCap | -0.02 | 1 per month | 0.94 | 0.06 | 1.50 | -1.50 | 6.05 | |
| CNBS | Amplify Seymour Cannabis | -0.61 | 4 per month | 5.61 | 0.05 | 9.19 | -6.90 | 80.06 |
Innovator IBD Additional Predictive Modules
Most predictive techniques to examine Innovator price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Innovator using various technical indicators. When you analyze Innovator charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Innovator IBD Market Sentiment and News Impact
Methodology
Unless otherwise specified, data for Innovator IBD 50 is derived from fund disclosures (prospectus language, holdings reports, and periodic statements where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on instrument type. Innovator (USA Stocks:FFTY) market data and reported NAV may reflect delayed updates. Data may be delayed depending on reporting sources and market conventions Analyst consensus data and sentiment signals are derived from publicly available research and media sources and reflect a point-in-time view. Indicative intraday values (IIV), where published, may provide additional context for premium or discount behavior relative to reported NAV.
Assumptions
We use public fund disclosures, holdings reports, and market data feeds with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Research Sources
Innovator IBD 50 may have reference inputs that incorporate holdings disclosures, category classification, and NAV-derived statistics where available. Updates may occur throughout the day.